Staging Lung Cancer: Metastasis
- PMID: 29622076
- DOI: 10.1016/j.rcl.2018.01.009
Staging Lung Cancer: Metastasis
Abstract
The updated eighth edition of the tumor, node, metastasis (TNM) classification for lung cancer includes revisions to T and M descriptors. In terms of the M descriptor, the classification of intrathoracic metastatic disease as M1a is unchanged from TNM-7. Extrathoracic metastatic disease, which was classified as M1b in TNM-7, is now subdivided into M1b (single metastasis, single organ) and M1c (multiple metastases in one or multiple organs) descriptors. In this article, the rationale for changes in the M descriptors, the utility of preoperative staging with PET/computed tomography, and the treatment options available for patients with oligometastatic disease are discussed.
Keywords: Metastasis; Oligometastatic disease; PET/CT; TNM-7; TNM-8.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Role of FDG PET/CT in the Eighth Edition of TNM Staging of Non-Small Cell Lung Cancer.Radiographics. 2018 Nov-Dec;38(7):2134-2149. doi: 10.1148/rg.2018180060. Radiographics. 2018. PMID: 30422775 Review.
-
Clinical relevance of the M1b and M1c descriptors from the proposed TNM 8 classification of lung cancer.Strahlenther Onkol. 2017 May;193(5):392-401. doi: 10.1007/s00066-017-1118-9. Epub 2017 Feb 28. Strahlenther Onkol. 2017. PMID: 28246699 English.
-
M1b Disease in the 8th Edition of TNM Staging of Lung Cancer: Pattern of Single Extrathoracic Metastasis and Clinical Outcome.Oncologist. 2019 Aug;24(8):e749-e754. doi: 10.1634/theoncologist.2018-0596. Epub 2019 Jan 29. Oncologist. 2019. PMID: 30696724 Free PMC article.
-
Prognostic Impact of Newly Proposed M Descriptors in TNM Classification of Non-Small Cell Lung Cancer.J Thorac Oncol. 2017 Mar;12(3):520-528. doi: 10.1016/j.jtho.2016.11.2216. Epub 2016 Nov 17. J Thorac Oncol. 2017. PMID: 27867003 Clinical Trial.
-
The new 8th TNM staging system of lung cancer and its potential imaging interpretation pitfalls and limitations with CT image demonstrations.Diagn Interv Radiol. 2019 Jul;25(4):270-279. doi: 10.5152/dir.2019.18458. Diagn Interv Radiol. 2019. PMID: 31295144 Free PMC article. Review.
Cited by
-
Nivolumab plus Ipilimumab versus Existing Immunotherapies in Patients with PD-L1-Positive Advanced Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis.Cancers (Basel). 2020 Jul 15;12(7):1905. doi: 10.3390/cancers12071905. Cancers (Basel). 2020. PMID: 32679702 Free PMC article. Review.
-
Brigatinib and Alectinib for ALK Rearrangement-Positive Advanced Non-Small Cell Lung Cancer With or Without Central Nervous System Metastasis: A Systematic Review and Network Meta-Analysis.Cancers (Basel). 2020 Apr 10;12(4):942. doi: 10.3390/cancers12040942. Cancers (Basel). 2020. PMID: 32290309 Free PMC article. Review.
-
IL‑21/IL‑21R inhibit tumor growth and invasion in non‑small cell lung cancer cells via suppressing Wnt/β‑catenin signaling and PD‑L1 expression.Int J Mol Med. 2019 Nov;44(5):1697-1706. doi: 10.3892/ijmm.2019.4354. Epub 2019 Sep 26. Int J Mol Med. 2019. PMID: 31573051 Free PMC article.
-
Bioinformatics Analysis and Screening of Potential Target Genes Related to the Lung Cancer Prognosis.Med Princ Pract. 2023 Sep 14:1. doi: 10.1159/000533891. Online ahead of print. Med Princ Pract. 2023. Retraction in: Med Princ Pract. 2025;34(4):404. doi: 10.1159/000545239. PMID: 37708874 Free PMC article. Retracted.
-
The radical approach to the oligometastatic not small cell lung cancer patient: which? how? when? where?J Thorac Dis. 2019 Sep;11(Suppl 15):S2023-S2025. doi: 10.21037/jtd.2019.06.28. J Thorac Dis. 2019. PMID: 31632815 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical